Suchergebnisse - "Beksaç, Meral"

PubPharm (45)

1

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma : A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Oriol, A. | Dimopoulos, M. | Schjesvold, F. | +12

2

Carfilzomib, daratumumab, and dexamethasone (KdD) vs. lenalidomide-sparing pomalidomide-containing triplet regimens for relapsed/refractory multiple myeloma : an indirect treatment comparison

enthalten in: Leukemia & lymphoma | 2024

von Weisel, K. | Dimopoulos, M. | Beksac, M. | +7

3

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P. | Dimopoulos, M. | Boccadoro, M. | +141

CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009

4

Carfilzomib, lenalidomide and dexamethasone followed by a second ASCT is an effective strategy in first relapse multiple myeloma : a study on behalf of the Chronic malignancies working party of the EBMT

enthalten in: Bone marrow transplantation | 2023

von Tilmont, R. | Yakoub-Agha, I. | Eikema, D. | +23

5

Subcutaneous daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma (APOLLO) : extended follow up of an open-label, randomised, multicentre, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Dimopoulos, M. | Terpos, E. | Boccadoro, M. | +18

6

Impact of newly diagnosed extramedullary myeloma on outcome after first autograft followed by maintenance : A CMWP-EBMT study

enthalten in: European journal of haematology | 2023

von Gagelmann, N. | Eikema, D. | Koster, L. | +22

7

Management of multiple myeloma-related renal impairment : recommendations from the International Myeloma Working Group

enthalten in: The Lancet. Oncology | 2023

von Dimopoulos, M. | Merlini, G. | Bridoux, F. | +25

8

Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR) : A Randomized, Open-Label, Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Sonneveld, P. | Chanan-Khan, A. | Weisel, K. | +16

CommentIn: J Clin Oncol. 2023 May 10;41(14):2668. - PMID 36940403

9

Generic Lenalidomide Rivelime Versus Brand-name Revlimid® in the Treatment of Relapsed/Refractory Multiple Myeloma : A Retrospective Single-center Experience on Efficacy, Safety and Survival Outcome

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Beksac, M. | Seval, G. | Koyun, D. | +4

10

Evaluation of isatuximab in patients with soft-tissue plasmacytomas : An analysis from ICARIA-MM and IKEMA

enthalten in: Leukemia research | 2022

von Beksac, M. | Spicka, I. | Hajek, R. | +9

1
2
3
4
5
Nächster »
[5]